ras peptide cancer vaccine

Biologicalexperimental

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ras peptide cancer vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00006387Phase 1Oct 1, 2000National Cancer Institute (NCI), Temple University
NCT00005630Phase 1Jul 1, 1999Cornell University, National Cancer Institute (NCI)
NCT00003959Phase 1Jun 1, 1999Cornell University, National Cancer Institute (NCI)
NCT00019591Phase 1/Phase 2 (Phase 2)Mar 1, 1999National Cancer Institute (NCI), National Institutes of Health (NIH)
NCT00019331Phase 2Oct 1, 1997National Cancer Institute (NCI)
NCT00019084Phase 2Feb 1, 1996National Cancer Institute (NCI)
NCT00019006Phase 1Mar 1, 1995National Cancer Institute (NCI)
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Institute (NCI)Government7421995
Cornell UniversityAcademic/Hospital2211999
National Institutes of Health (NIH)Government1011999
Temple UniversityAcademic/Hospital1112000
4 organizations
Page 1 / 1